ES / EN
- July 10, 2025 -
No Result
View All Result
OnCubaNews
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors
OnCubaNews
ES / EN
Home Cuba Science Health in Cuba

Cuba begins large-scale production of Abdala, one of its four COVID-19 vaccines

The president of BioCubaFarma, Eduardo Martínez, announced this Wednesday on his Twitter account the start of the manufacturing at Aica laboratories of a batch of the vaccine.

by
  • OnCuba Staff
    OnCuba Staff,
  • OnCuba editorial staff
February 26, 2021
in Health in Cuba, Science in Cuba
0
Vaccine candidate

Photo: @AicaLaboratorio/Twitter.

Cuba began industrial production of the Abdala COVID-19 vaccine candidate to ensure the doses required in the third phase of clinical trials, Cubadebate reported.

The president of BioCubaFarma, Eduardo Martínez, announced this Wednesday on his Twitter account the start of the manufacturing at Aica laboratories of a batch of the vaccine.

Otro de nuestros candidatos vacunales, #Abdala, también comenzó el proceso de fabricación industrial. En este momento @AicaLaboratorio, se encuetra produciendo los lotes de vacunas que se utilizarán en los Estudios Clínicos Fase III. #CubaViva pic.twitter.com/cVckDPgWRV

— Eduardo Martínez Díaz (@EdMartDiaz) February 24, 2021

Developed by the Center for Genetic Engineering and Biotechnology (CIGB), Abdala has demonstrated safety and immunogenicity against coronavirus in the second phase of clinical studies.

For their part, officials of the Cuban biopharmaceutical industry explained that their plants have enough capacity to produce more than 100,000 bulbs per day of the vaccine candidate, at a rate of 12,000 doses per hour, according to the source.

Authorities from the BioCubaFarma business group and the Finlay Vaccine Institute (IFV) confirmed this weekend the large-scale production of Soberana 02, at the National Center for Biopreparations (BIOCEN).

Related Posts

Center for Molecular Immunology

Non-alpha IL-2 Mutein: a Cuban hope for cancer

May 11, 2025
Dr. Tareq Zaid with a patient. Photo: Courtesy of the interviewee.

Dr. Tareq: the story of a Palestinian-Cuban doctor

March 3, 2025
Photo: Canva.

Psychosomatic illnesses: Can the mind make the body sick?

November 10, 2024
Itolizumab. Photo taken from Radio Habana Cuba

Itolizumab, the monoclonal antibody designed in Cuba, is making its way into the world

October 25, 2024

The third phase of clinical trials with this formulation developed by the Finlay Institute will begin in March in Havana.

Third phase of trials of Soberana 02 vaccine to start in March in Havana

The director general of the IFV, Dr. Vicente Vérez, affirmed yesterday that this vaccine candidate has demonstrated a “high degree of safety and reliability” in the preceding trials, Tribuna de La Habana reported.

Cuba intends to immunize its entire population this year, which is why it advances in the development of four vaccine candidates in unison; in addition to Soberana 02 and Abdala, the island’s scientists continue the studies of the Soberana 01 and Mambisa candidates.

  • OnCuba Staff
    OnCuba Staff,
  • OnCuba editorial staff
Tags: Cuban medicine against COVID-19Cuban vaccine against COVID-19
Previous Post

Coronavirus in Cuba: 875 new infections, two deaths and 906 discharges

Next Post

Cayo Santamaría and Varadero among best 25 beaches worldwide, according to TripAdvisor

OnCuba Staff

OnCuba Staff

OnCuba Staff

OnCuba Staff

Next Post
Varadero

Cayo Santamaría and Varadero among best 25 beaches worldwide, according to TripAdvisor

obstetric violence

Our fragments, talking about obstetric violence and respected childbirth (I)

Article

Our fragments, speaking of obstetric violence and respected childbirth (II and final)

Leave a Reply Cancel reply

The conversation here is moderated according to OnCuba News discussion guidelines. Please read the Comment Policy before joining the discussion.

Your email address will not be published. Required fields are marked *

Most Read

  • Flags of Cuba and the United States, seen in perspective in Havana. Photo: Otmaro Rodríguez.

    Trump reinstates hard-line Cuba embargo as Havana condemns US measure as “criminal”

    29 shares
    Share 12 Tweet 7
  • Lester Lescay: “I left Cuba because I didn’t want to spend my youth there.”

    16 shares
    Share 6 Tweet 4
  • San Juan Hill: heritage in the attic?

    12 shares
    Share 5 Tweet 3
  • Los Palacios, land of Cuban rice harvested by Vietnamese

    11 shares
    Share 4 Tweet 3
  • A sanctuary for jazz in Cuba: César López’s dream

    15 shares
    Share 6 Tweet 4

Most Commented

  • Photo: Kaloian.

    Private sector and tourism in Cuba. Why not?

    12 shares
    Share 5 Tweet 3
  • About us
  • Work with OnCuba
  • Terms of use
  • Privacy Policy
  • Moderation policy for comments
  • Contact us
  • Advertisement offers

OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.

No Result
View All Result
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors

OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}